Welcome to our dedicated page for Cea Industries SEC filings (Ticker: BNCWW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
CEA Industries Inc. filings document material-event reporting for a public company centered on a BNB digital asset treasury strategy. Recent 8-K disclosures cover a master loan agreement for borrowing digital assets or cash, collateral arrangements that may include BNB or cash, financial covenants, and related default and margin-call provisions.
The filing record also includes Regulation FD disclosures on Stapled Warrants, warrant agreement terms and Nasdaq trading, executive appointments, compensatory arrangements, restricted stock unit inducement grants, and communications about asset-management arrangements. These filings describe capital structure, treasury financing, governance, equity compensation, and risk-linked contractual obligations.
CEA Industries Inc. filed a current report to let investors know it has shared a new letter with its shareholders. The letter, dated September 21, 2025, explains that the company filed a registration statement on September 19, 2025 to register securities issued in a recently completed PIPE transaction and a related warrant transaction, and it also provides an update on the company’s operations. The shareholder letter is included as Exhibit 99.1 to this report, but the company specifies that this information is being furnished under Regulation FD and is not treated as filed for liability purposes under the securities laws.
CEA Industries, Inc. (BNCWW) filed an S-3ASR prospectus registration that lists the securities being registered for resale by numerous selling stockholders and describes the offering mechanics and estimated expenses. The prospectus excerpt names over a hundred institutional and individual selling stockholders with specific share quantities each intends to offer, including material positions such as YZi Labs Management Ltd. holding 23,366,341 shares as of September 19, 2025. The filing also discloses aggregate instruments tied to the offering: 2,150,481 shares of Common Stock, 7,750,510 shares underlying Pre-Funded Warrants, 9,900,991 shares underlying Stapled Warrants and 3,564,359 shares underlying Strategic Advisor Warrants (assumptions include full exercise and sale of the referenced warrants).
The document includes a prospectus table of contents, use-of-proceeds categories (working capital, capital expenditures, share repurchases, debt repayment, and pursuit of a BNB treasury strategy), a schedule of estimated offering expenses, and standard selling-stockholder beneficial ownership and control disclaimers tied to each named holder.